SLS, IBRX And IOVA Join Merck And Lilly On BlackRock’s Q3 Buy List — A Vanguard Unit Adds All Of Them Too
BlackRock and Vanguard Capital Management added all five stocks in Q3, including 8.12 million shares across SLS, IBRX and IOVA.
BlackRock and Vanguard Capital Management added all five stocks in Q3, including 8.12 million shares across SLS, IBRX and IOVA.